Kiniksa Pharmaceuticals shares owned by MetLife Investment Advisors
Quarter-by-quarter ownership of Kiniksa Pharmaceuticals (KNSA) shares owned by MetLife Investment Advisors
from 13F filings
Historical chart of MetLife Investment Advisors investment in Kiniksa Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Kiniksa Pharmaceuticals held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Kiniksa Pharmaceuticals by MetLife Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $304k | 17k | 17.54 |
| 2023-09-30 | $301k | 17k | 17.37 |
| 2023-06-30 | $244k | 17k | 14.08 |
| 2022-12-31 | $260k | 17k | 14.98 |
| 2022-09-30 | $223k | 17k | 12.84 |
| 2022-06-30 | $168k | 17k | 9.69 |
| 2022-03-31 | $172k | 17k | 9.94 |
| 2021-12-31 | $131k | 11k | 11.77 |
| 2021-09-30 | $126k | 11k | 11.39 |
| 2021-03-31 | $205k | 11k | 18.51 |
| 2020-12-31 | $217k | 12k | 17.67 |
| 2020-09-30 | $188k | 12k | 15.32 |
| 2020-06-30 | $229k | 9.0k | 25.48 |
| 2020-03-31 | $110k | 7.1k | 15.48 |
More positions owned by MetLife Investment Advisors
View all positions for MetLife Investment Advisors